Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 4, keine Gesamtzahl für „serious“
Suchtreffer
Begriffe & Kennungen
Alymsys · 4.8 · Fatal outcome was reported in approximately a third of serious cases of gastrointestinal perforations, which r
Eintrag öffnenAlymsys · 4.8 · Serious wound healing complications, including anastomotic complications, have been reported, some of which ha
Eintrag öffnenAlymsys · 4.8 · The most serious adverse reactions were:
Eintrag öffnenAlymsys · 4.8 · Within each frequency category, adverse reactions are presented in the order of decreasing seriousness.
Eintrag öffnenAmbrisentan Viatris (previously Ambrisentan Mylan) · 4.8 · Serious adverse reactions associated with ambrisentan use include anaemia (decreased haemoglobin, decreased ha
Eintrag öffnenAmgevita · 4.8 · 16 Serious adverse reactions have been reported for adalimumab. TNF-antagonists, such as AMGEVITA affect the i
Eintrag öffnenAmgevita · 4.8 · 70 Serious haematological, neurological and autoimmune reactions have also been reported. These include rare r
Eintrag öffnenAmgevita · 4.8 · In adult Crohn’s disease studies, higher incidences of malignant and serious infection-related adverse events
Eintrag öffnenAmgevita · 4.8 · In adult Crohn’s disease studies, higher incidences of malignant and serious infection-related adverse events
Eintrag öffnenAmgevita · 4.8 · In controlled and open-label adult and paediatric studies with adalimumab, serious infections (including fatal
Eintrag öffnenAmgevita · 4.8 · In controlled and open-label adult and paediatric studies with adalimumab, serious infections (including fatal
Eintrag öffnenAmgevita · 4.8 · Serious adverse reactions have been reported for adalimumab. TNF-antagonists, such as AMGEVITA affect the immu
Eintrag öffnenAmgevita · 4.8 · Serious haematological, neurological and autoimmune reactions have also been reported. These include rare repo
Eintrag öffnenAmgevita · 4.8 · The incidence of serious infections was 0.04 per patient year in adalimumab-treated patients and 0.03 per pati
Eintrag öffnenAmgevita · 4.8 · The incidence of serious infections was 0.04 per patient year in adalimumab-treated patients and 0.03 per pati
Eintrag öffnenAmglidia · 4.8 · Within each frequency grouping, adverse reactions are presented in order of decreasing seriousness.
Eintrag öffnenAmsparity · 4.8 · 12 Serious haematological, neurological and autoimmune reactions have also been reported. These include rare r
Eintrag öffnenAmsparity · 4.8 · In adult Crohn’s disease studies, higher incidences of malignant and serious infection-related adverse events
Eintrag öffnenAmsparity · 4.8 · In adult Crohn’s disease studies, higher incidences of malignant and serious infection-related adverse events
Eintrag öffnenAmsparity · 4.8 · In adult Crohn’s disease studies, higher incidences of malignant and serious infection-related adverse events
Eintrag öffnen